2017 | Development and validation of the modified charlson comorbidity index in incident peritoneal dialysis patients: A national population-based approach | 류동열 | Article |
2019 | Dialysis modality-related disparities in sudden cardiac death: Hemodialysis versus peritoneal dialysis | 류동열 | Article |
2023 | Dialysis specialist care and patient survival in hemodialysis facilities: a Korean nationwide cohort study | 류동열 | Article |
2015 | Diastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic function | 류동열 | Article |
2016 | Difference in stroke incidence between Korean and Japanese patients initiating dialysis - Era or ethnic effect? | 류동열 | Letter |
2007 | Differential expression of nephrin according to glomerular size in early diabetic kidney disease | 류동열 | Article |
2015 | Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells | 강덕희; 최규복; 이현국; 김승정; 류동열 | Article |
2019 | Effect of Renin-angiotensin system blockade on mortality in Korean hypertensive patients with proteinuria | 류동열; 오형중 | Article |
2017 | Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): A study protocol for a randomized controlled trial | 류동열 | Article |
2020 | Estimation of population-based utility weights for health states of chronic kidney disease, dialysis and kidney transplantation | 류동열 | Article |
2022 | Evaluating a shared decision-making intervention regarding dialysis modality: development and validation of self-assessment items for patients with chronic kidney disease | 류동열; 안순태; 김수진 | Article |
2014 | Excess mortality among patients on dialysis: Comparison with the general population in Korea | 한후재; 류동열 | Article |
2019 | Fracture risk in chronic kidney disease: A Korean population-based cohort study | 류동열; 오형중 | Article |
2023 | Hemodialysis facility star rating affects mortality in chronic hemodialysis patients: A longitudinal observational cohort study | 류동열 | Article |
2008 | High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cells | 류동열 | Article |
2019 | Impact of chronic kidney disease on mortality: A nationwide cohort study | 류동열; 오형중 | Article |
2011 | Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients | 류동열 | Article |
2011 | Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions | 류동열 | Article |
2008 | MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells | 류동열 | Article |
2017 | Middle east respiratory syndrome clinical practice guideline for hemodialysis facilities | 최규복; 류동열 | Article |
2011 | Non-dipper status and left ventricular hypertrophy as predictors of incident chronic kidney disease | 강덕희; 최규복; 김승정; 류동열 | Article |
2022 | Nurse Caseload and Patient Survival in Hemodialysis Units: A Korean Nationwide Cohort Study | 류동열 | Article |
2022 | Optimal target blood pressure for major adverse cardiovascular and cerebrovascular events in hypertensive patients: A nationwide population-based study | 류동열 | Article |
2007 | Podocyte biology in diabetic nephropathy | 류동열 | Conference Paper |
2014 | Prime determinants of serum phosphorus level in hemodialysis patients | 류동열 | Letter |
2015 | Recalibration and validation of the Charlson comorbidity index in Korean incident hemodialysis patients | 류동열 | Article |
2017 | Risk of stroke in elderly dialysis patients | 류동열 | Article |
2016 | Technique failure in Korean incident peritoneal dialysis patients: a national population-based study | 한후재; 강덕희; 최규복; 김승정; 류동열 | Article |
2017 | The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions | 류동열 | Article |
2017 | The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol | 류동열 | Editorial |